People · Operator
Named in public records as an officer, director or promoter · active 2009–2014 · Pharmaceuticals, Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Neos Therapeutics, Inc. | — | Pharmaceuticals | Series B | $163.6M | $701.3M | 2009 |
| AliveCor, Inc. | — | Other Health Care | Series C | $105.9M | $1.2B | 2011 |
| Wavetec Vision Systems Inc | — | Other Health Care | Series B | $99.9M | $64.1M | 2014 |
| Logical Therapeutics Inc | — | Biotechnology | Series B | $42.5M | $396.9M | 2010 |
| Odyssey Thera Inc. | — | Biotechnology | Seed | $3.5M | $155.4M | 2010 |
Bryant Fong at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Bryant Fong on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Bruce Feuchter | 1 | 12 |
| Vinod Khosla | 1 | 12 |
| G. Steven Burrill | 1 | 7 |
| Gerard Van Hamel Platerink | 1 | 6 |
| Lutz Giebel | 1 | 6 |
| Anthony Lando | 1 | 6 |
| James Tananbaum | 1 | 6 |
| Joe Mandato | 1 | 5 |
| Paul Schmitt | 1 | 5 |
| Martin Edwards | 1 | 5 |
| Scott Cooper | 1 | 5 |
| John Clark | 1 | 5 |
| Charles Warden | 1 | 5 |
| Edward Schnipper | 1 | 4 |
| Toby Cosgrove | 1 | 4 |
| Victor Miller | 1 | 4 |
| John Westwick | 1 | 3 |
| Karl Handelsman | 1 | 3 |
| Bryan Hill | 1 | 3 |
| Ryan Phillips | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.